Selegiline

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3161 publications

Predicting the potential for organic cation transporter 1-mediated drug-drug interactions with fenoterol by amitriptyline, fluoxetine, selegiline, metformin, and verapamil.

Predicting the potential for organic cation transporter 1-mediated drug-drug interactions with fenoterol by amitriptyline, fluoxetine, selegiline, metformin, and verapamil.

Journal: Expert opinion on drug metabolism & toxicology

Published: March 19, 2026

An Innovative RP-HPLC Strategy for Dual-Drug Analysis: Simultaneous Estimation of Selegiline and Biochanin A in Bulk and SNEDDS.

An Innovative RP-HPLC Strategy for Dual-Drug Analysis: Simultaneous Estimation of Selegiline and Biochanin A in Bulk and SNEDDS.

Journal: Drug development and industrial pharmacy

Published: March 14, 2026

Electron Pool Enrichment of Polyhedral Carboranes: A Key to Isomerization and Nucleophilicity.

Electron Pool Enrichment of Polyhedral Carboranes: A Key to Isomerization and Nucleophilicity.

Journal: Inorganic chemistry

Published: March 12, 2026

Catecholaminergic storm and extreme blood pressure lability induced by combined levodopa/benserazide, selegiline, and piribedil in Parkinson's disease: a case report.

Catecholaminergic storm and extreme blood pressure lability induced by combined levodopa/benserazide, selegiline, and piribedil in Parkinson's disease: a case report.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: January 30, 2026

Determination of R/S-enantiomers of methamphetamine and amphetamine in human hair with chiral stationary phase LC-MS/MS.

Determination of R/S-enantiomers of methamphetamine and amphetamine in human hair with chiral stationary phase LC-MS/MS.

Journal: Bioanalysis

Published: January 30, 2026

Pharmacokinetics and pharmacodynamics of anti-Parkinson drugs in geriatric patients : Key for optimization of treatment

Pharmacokinetics and pharmacodynamics of anti-Parkinson drugs in geriatric patients : Key for optimization of treatment

Journal: Zeitschrift fur Gerontologie und Geriatrie

Published: December 19, 2025

Evaluation of Pyrrole Heterocyclic Derivatives as Selective MAO-B Inhibitors and Neuroprotectors.

Evaluation of Pyrrole Heterocyclic Derivatives as Selective MAO-B Inhibitors and Neuroprotectors.

Journal: Molecules (Basel, Switzerland)

Published: December 13, 2025

Case Report: A possible novel adult-onset, progressive MAO-A hypofunction.

Case Report: A possible novel adult-onset, progressive MAO-A hypofunction.

Journal: Frontiers in neuroscience

Published: December 01, 2025

Correction to "The MAO-B Inhibitor Selegiline Reduces the Viability of Different Prostate Cancer Cell Lines and Enhances the Effects of Anti-Androgen and Cytostatic Agents".

Correction to "The MAO-B Inhibitor Selegiline Reduces the Viability of Different Prostate Cancer Cell Lines and Enhances the Effects of Anti-Androgen and Cytostatic Agents".

Journal: Pharmacology research & perspectives

Published: November 29, 2025

Validation of the Brief Children's Depression Rating Scale in Children Treated With Selegiline Transdermal Patch vs Placebo.

Validation of the Brief Children's Depression Rating Scale in Children Treated With Selegiline Transdermal Patch vs Placebo.

Journal: JAACAP open

Published: November 24, 2025

Efficacy of MAO-B and COMT inhibitors on quality of life in patients with Parkinson's disease: a Bayesian network meta-analysis.

Efficacy of MAO-B and COMT inhibitors on quality of life in patients with Parkinson's disease: a Bayesian network meta-analysis.

Journal: Frontiers in neurology

Published: November 24, 2025

Consensus Molecules Associated with Parkinson's Disease.

Consensus Molecules Associated with Parkinson's Disease.

Journal: Neurology international

Published: November 20, 2025

Showing 1-12 of 3,161

Last Updated: 04/28/2026